The exclusion of breast cancer patients with a family history of breast cancer had a minor impact on PTV association with overall breast cancer risk (i.e., BRCA2 adjusted OR of 8.74; 1.57-48.75 95% CI, p-value = 0.013) (Supplementary Table S5). Here, BRCA2 is linked to breast carcinoma.